Fan Hongwei
Fan Hongwei () is a Chinese entrepreneur and billionaire who is the chair and CEO of the chemical fiber company Hengli Petrochemical (恒力石化) and vice chair of its holding company Hengli Group (恒力集团). She was the fourth richest woman in China in 2019. Provided by Wikipedia
Showing 1 - 16 results of 16 for search 'Hongwei Fan', query time: 0.06s
Refine Results
-
1
-
2
Anhydrous interfacial polymerization of sub-1 Å sieving polyamide membrane by Guangjin Zhao, Haiqi Gao, Zhou Qu, Hongwei Fan, Hong Meng
Published 2023-11-01
Article -
3
-
4
-
5
Pore engineering in covalent organic framework membrane for gas separation by Zhou Qu, Chenyu Lai, Guangjin Zhao, Alexander Knebel, Hongwei Fan, Hong Meng
Published 2022-01-01
Article -
6
Numerical Study on Ultrasonic Guided Waves for the Inspection of Polygonal Drill Pipes by Xiang Wan, Xuhui Zhang, Hongwei Fan, Peter W. Tse, Ming Dong, Hongwei Ma
Published 2019-05-01
Article -
7
Influence Rule of Annular Notch Geometric Parameter on the Tubing Surface: A Case Study by Renfeng Zhao, Weicheng Gao, Dongya Zhang, Xudong Xiao, Yanwei Liu, Runze Pan, Hongwei Fan
Published 2022-06-01
Article -
8
-
9
-
10
Sprayed separation membranes: A systematic review and prospective opportunities by Guangjin Zhao, Wenjing Han, Liangliang Dong, Hongwei Fan, Zhou Qu, Jiahui Gu, Hong Meng
Published 2022-12-01
Article -
11
An Arc-Shaped Piezoelectric Bistable Vibration Energy Harvester: Modeling and Experiments by Xuhui Zhang, Wenjuan Yang, Meng Zuo, Houzhi Tan, Hongwei Fan, Qinghua Mao, Xiang Wan
Published 2018-12-01
Article -
12
-
13
A Method for Parameter Identification of Composite Beam Piezoelectric Energy Harvester by Xuhui Zhang, Chao Zhang, Lin Wang, Luyang Chen, Xiaoyu Chen, Dongmei Xu, Hongwei Fan, Fulin Zhu
Published 2021-10-01
Article -
14
Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial by Junlin Cheng, Jun Long, Jingjing Zhang, Le Han, Yunfang Hu, Jianghui Liu, Runze Qiu, Zhibin Zhu, Hongwei Fan
Published 2023-04-01
Article -
15
-
16
The unreversible reduced but persistent activated NK and CD8+ T cells in severe/critical COVID-19 during omicron pandemic in China by Ling Qin, Xinmin Duan, Jay Zengjun Dong, Yue Chang, Yang Han, Yan Li, Wei Jiang, Hongwei Fan, Xiufeng Hou, Wei Cao, Huadong Zhu, Taisheng Li
Published 2023-12-01
Article